The circadian clock and the hypoxic response pathway in kidney cancer

Area of Science:

• Oncology
• Molecular Biology
• Chronobiology

Background:

• Renal cell carcinoma (RCC) is the most common malignant kidney tumor in adults, often lethal due to metastasis at diagnosis.
• A key molecular feature of sporadic RCC is the mutation of the von Hippel-Lindau (VHL) tumor suppressor gene, leading to altered cellular pathways and activated hypoxia-inducible factors.
• Hypoxia-inducible factors regulate genes involved in oxygen homeostasis, metabolism, neovascularization, cell survival, and migration, promoting tumor growth.

Purpose of the Study:

• To investigate the interrelationship between the hypoxic response pathway and the circadian pathway in kidney cancer.
• To explore how deregulation of clock genes and hypoxia-related pathways influences renal cell carcinoma (RCC) development, progression, and patient outcomes.

Main Methods:

• The study analyzed alterations in clock gene expression.
• The study examined hypoxia-correlated pathways in kidney cancer patients.
• Correlation analysis was performed between circadian clock genes and hypoxia-response pathways.

Main Results:

• Severe deregulation of genes within the circadian clock circuitry was observed in kidney cancer patients.
• Significant alterations in genes responding to hypoxia were also found in these patients.
• These deregulations were linked to kidney cancer's carcinogenesis, progression, and overall outcome.

Conclusions:

• The interplay between circadian rhythm and hypoxia pathways is significantly disrupted in kidney cancer.
• Understanding these alterations in clock gene expression and hypoxia pathways is crucial for comprehending renal cell carcinoma (RCC) pathophysiology.
• This research may pave the way for developing more effective therapeutic strategies for kidney cancer.